DRUG FIRM TEKMIRA SAYS FDA MAY ALLOW USE OF EBOLA DRUG ON PATIENTS

MANAGE SUBSCRIPTIONS   |   UNSUBSCRIBE   |   VIEW ONLINE   Markets Select   August 08, 2014 DRUG FIRM TEKMIRA SAYS FDA MAY ALLOW USE OF EBOLA DRUG ON PATIENTS Individuals infected with the Ebola virus might be able to get access to... Read» Share this story: Ordinary Russians Are Furious About Putin's New Food Sanctions On Thursday we learned Russia will ban the imports of meat, dairy...  Read» Share this story: RECORD WITHDRAWALS FROM HIGH-YIELD BOND FUNDS High yield bond funds have posted $7.1 billion in outflows according to...  Read» Share this story: The 15 US Cities Where Poverty Is Soaring Fastest Southern poverty has grown in an extreme way within America's...  Read» Share this story: 3D Printing Company Stratasys Is Soaring Stratasys shares were up as much as 19% Thursday after the 3-D...  Read» German Interest Rates Go Negative The German bond market is considered one of the safe havens for...  Read» Shares In One Of America's Largest Solar Operators Are Surging Shares in SunEdison, one of America's largest solar panel systems...  Read» Advertisement Consumer Credit Balances Rose Less Than Expected Consumer credit balances expanded by $17.25 billion in June. This is...  Read» Share this story: European Markets Are Down, US Futures Are Up European markets are down on Thursday after Russia said it would ban all...  Read» Share this story: See Also German Economic Data Has Been Astonishingly Bad German economic data has been unquestionably bad in recent days...   Read»   Chicken Stocks Are Getting Whacked Shares of U.S. poultry producers are down today after Russia announced...   Read»   JOBLESS CLAIMS PLUNGE TO AN 8-YEAR LOW Initial jobless claims plunged to 289,000 from a revised 303,000 prior...   Read»   Goldman Sachs Economist Dashes Our Hopes For A Big US Business Spending Boom One of the big bullish arguments on the US recovery is that companies...   Read»   Share: Share: Share: Share: Share this: Email sent to: ipat39@gmail.com   |   Manage your email preferences   |   Unsubscribe Terms of Service   |   Privacy Policy Business Insider. 150 Fifth Avenue, New York, NY 10011